A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, ACTIVE AND PLACEBO CONTROLLED STUDY OF PF-04171327 IN THE TREATMENT OF THE SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS

Update Il y a 4 ans
Reference: EUCTR2009-013223-37

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the efficacy of PF-04171327 (high and low dose) compared to placebo as assessed by DAS28-4 (CRP) at Week 2


Inclusion criteria

  • Rheumatoid Arthritis